171 related articles for article (PubMed ID: 18264998)
1. Limitations of conventionally derived chronic liver disease mortality rates: Results of a comprehensive assessment.
Manos MM; Leyden WA; Murphy RC; Terrault NA; Bell BP
Hepatology; 2008 Apr; 47(4):1150-7. PubMed ID: 18264998
[TBL] [Abstract][Full Text] [Related]
2. Deaths from chronic liver disease and viral hepatitis, Multnomah County, Oregon, 2000.
Thomas AR; Zaman A; Bell BP
J Clin Gastroenterol; 2007 Oct; 41(9):859-62. PubMed ID: 17881933
[TBL] [Abstract][Full Text] [Related]
3. Chronic liver disease mortality in the United States, 1990-1998.
Vong S; Bell BP
Hepatology; 2004 Feb; 39(2):476-83. PubMed ID: 14768001
[TBL] [Abstract][Full Text] [Related]
4. The mortality burden of chronic liver disease may be substantially underestimated in the United States.
Durante AJ; St Louis T; Meek JI; Navarro VJ; Sofair AN
Conn Med; 2008 Aug; 72(7):389-92. PubMed ID: 18763665
[TBL] [Abstract][Full Text] [Related]
5. Measuring chronic liver disease mortality using an expanded cause of death definition and medical records in Connecticut, 2004.
Ly KN; Speers S; Klevens RM; Barry V; Vogt TM
Hepatol Res; 2015 Sep; 45(9):960-968. PubMed ID: 25319958
[TBL] [Abstract][Full Text] [Related]
6. Endemic hepatitis B virus infection and chronic liver disease mortality in the Republic of Palau, 1990-2002.
Vogt TM; Goldstein ST; Kuartei S
Trans R Soc Trop Med Hyg; 2006 Dec; 100(12):1130-4. PubMed ID: 16765396
[TBL] [Abstract][Full Text] [Related]
7. Chronic liver disease in central Harlem: the role of alcohol and viral hepatitis.
Frieden TR; Ozick L; McCord C; Nainan OV; Workman S; Comer G; Lee TP; Byun KS; Patel D; Henning KJ
Hepatology; 1999 Mar; 29(3):883-8. PubMed ID: 10051493
[TBL] [Abstract][Full Text] [Related]
8. The epidemiology of newly diagnosed chronic liver disease in gastroenterology practices in the United States: results from population-based surveillance.
Bell BP; Manos MM; Zaman A; Terrault N; Thomas A; Navarro VJ; Dhotre KB; Murphy RC; Van Ness GR; Stabach N; Robert ME; Bower WA; Bialek SR; Sofair AN
Am J Gastroenterol; 2008 Nov; 103(11):2727-36; quiz 2737. PubMed ID: 18684170
[TBL] [Abstract][Full Text] [Related]
9. Non-alcoholic fatty liver disease is associated with greater risk of 30-day hospital readmission in the United States (U.S.).
Paik JM; Eberly KE; Kabbara K; Harring M; Younossi Y; Henry L; Verma M; Younossi ZM
Ann Hepatol; 2023; 28(4):101108. PubMed ID: 37088421
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C and hepatitis B-related mortality in Spain.
García-Fulgueiras A; García-Pina R; Morant C; García-Ortuzar V; Génova R; Alvarez E
Eur J Gastroenterol Hepatol; 2009 Aug; 21(8):895-901. PubMed ID: 19357523
[TBL] [Abstract][Full Text] [Related]
11. The contribution of viral hepatitis to the burden of chronic liver disease in the United States.
Roberts HW; Utuama OA; Klevens M; Teshale E; Hughes E; Jiles R
Am J Gastroenterol; 2014 Mar; 109(3):387-93; quiz 386, 394. PubMed ID: 24445570
[TBL] [Abstract][Full Text] [Related]
12. Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study.
Stepanova M; Rafiq N; Younossi ZM
Gut; 2010 Oct; 59(10):1410-5. PubMed ID: 20660697
[TBL] [Abstract][Full Text] [Related]
13. Deaths: final data for 2000.
Miniño AM; Arias E; Kochanek KD; Murphy SL; Smith BL
Natl Vital Stat Rep; 2002 Sep; 50(15):1-119. PubMed ID: 12382630
[TBL] [Abstract][Full Text] [Related]
14. Chronic liver disease related mortality pattern in Northern Pakistan.
Khokhar N; Niazi SA
J Coll Physicians Surg Pak; 2003 Sep; 13(9):495-7. PubMed ID: 12971866
[TBL] [Abstract][Full Text] [Related]
15. Study of the causes of higher mortality rates from chronic liver diseases in Tokushima Prefecture.
Kamamura M; Honda H; Inoue H; Shinomiya H; Kubo K; Tsutsui A; Muguruma N; Shibata H; Shimizu I; Ito S
J Med Invest; 2002 Aug; 49(3-4):163-71. PubMed ID: 12323006
[TBL] [Abstract][Full Text] [Related]
16. Outcome of hospital care of liver disease associated with hepatitis C in the United States.
Kim WR; Gross JB; Poterucha JJ; Locke GR; Dickson ER
Hepatology; 2001 Jan; 33(1):201-6. PubMed ID: 11124837
[TBL] [Abstract][Full Text] [Related]
17. Deaths: preliminary data for 2002.
Kochanek KD; Smith BL
Natl Vital Stat Rep; 2004 Feb; 52(13):1-47. PubMed ID: 14998175
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of hepatocellular carcinoma in Canada, 1995: analysis of death certificates.
ElSaadany S; Giulivi A
Chronic Dis Can; 2006; 27(3):125-9. PubMed ID: 17306064
[TBL] [Abstract][Full Text] [Related]
19. Deaths: final data for 2003.
Hoyert DL; Heron MP; Murphy SL; Kung HC
Natl Vital Stat Rep; 2006 Apr; 54(13):1-120. PubMed ID: 16689256
[TBL] [Abstract][Full Text] [Related]
20. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
